Skip to content
Femasys Logo
Main Menu
  • Corporate
    • About Femasys
      • Who we are
      • Leadership
    • Investor Relations
      • Overview
      • News
      • Events & Presentations
      • Stock Info
      • Financials
      • Governance
      • Resources
    • Resources
    • Contact Us
      • Contact Femasys
      • Join Us
  • Healthcare Professionals
    • Infertility
      • FemaSeed
      • FemVue
    • Birth Control
    • Cancer Diagnosis
  • Patients
    • Infertility
      • FemVue
      • FemaSeed
    • Birth Control
    • Cancer Diagnosis

Category: Media

Meet the metro Atlanta woman who invented a new permanent birth control

The Future of Fertility and Non-Surgical Birth Control with Kathy Lee-Sepsick

Transforming women’s health: The power of Femtech and minimally invasive solutions

Intratubal insemination: Another Option in Fertility Treatment

Femasys Offers a Fresh Take on Women’s Reproductive Healthcare

Disrupting Stagnant Women’s Reproductive Health Ecosystem with Safer More Accessible Options with Kathy Lee-Sepsick Femasys

Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment

Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

← older
About Femasys
  • Who We Are
  • Leadership
Investor Relations
  • Overview
  • News
  • Event & Presentations
  • Stock Info
  • Financials
  • Governance
  • Resources
Resources
  • Who We Are
  • Leadership
Contact Us
  • Contact Femasys
  • Join Us
Healthcare Professionals
  • Infertility
  • Birth Control
  • Cancer Diagnosis
Patients
  • Infertility
  • Birth Control
  • Cancer Diagnosis
Privacy Policy
Terms of Use
Patents
Accessibility
Order
Copyright © 2024 Femasys Inc.
FemaSeed, FemBloc, FemCath, FemCerv, and FemVue are registered trademarks of Femasys Inc.
Main Menu
  • Corporate
    • About Femasys
      • Who we are
      • Leadership
    • Investor Relations
      • Overview
      • News
      • Events & Presentations
      • Stock Info
      • Financials
      • Governance
      • Resources
    • Resources
    • Contact Us
      • Contact Femasys
      • Join Us
  • Healthcare Professionals
    • Infertility
      • FemaSeed
      • FemVue
    • Birth Control
    • Cancer Diagnosis
  • Patients
    • Infertility
      • FemVue
      • FemaSeed
    • Birth Control
    • Cancer Diagnosis